Cite

HARVARD Citation

    Nio, K. et al. (2020). Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib. International journal of surgery. 5 (4), p. e89. [Online]. 
  
Back to record